Breast carcinoma by gene expression profile
MONDO:0006116A header term that includes the following breast carcinoma subtypes determined by gene expression profiling: luminal A breast carcinoma, luminal B breast carcinoma, HER2 positive breast carcinoma, basal-like breast carcinoma, triple-negative breast carcinoma, and normal breast-like subtype of breast carcinoma.
Also known as: breast carcinoma by gene expression profile
4494 clinical trials for this condition and its sub-types, 0 tagged with Breast carcinoma by gene expression profile itself.
Follow this condition to get notified about new trialsWhere it sits in the disease tree
Browse by category →Part of
Sub-types of Breast carcinoma by gene expression profile
-
Her2-receptor negative breast cancer 241 trials · 1,363 incl. sub-types
2 sub-types
- Triple-negative breast carcinoma 703 trials · 705 incl. sub-types Sub-types →
- Hormone receptor-positive breast cancer 636 trials
-
Estrogen-receptor positive breast cancer 183 trials · 773 incl. sub-types
2 sub-types
- Hormone receptor-positive breast cancer 636 trials
- Triple-positive breast carcinoma 33 trials
-
Estrogen-receptor negative breast cancer 24 trials · 707 incl. sub-types
1 sub-type
- Triple-negative breast carcinoma 703 trials · 705 incl. sub-types Sub-types →
-
Progesterone-receptor negative breast cancer 3 trials · 705 incl. sub-types
1 sub-type
- Triple-negative breast carcinoma 703 trials · 705 incl. sub-types Sub-types →
-
Progesterone-receptor positive breast cancer 16 trials · 662 incl. sub-types
2 sub-types
- Hormone receptor-positive breast cancer 636 trials
- Triple-positive breast carcinoma 33 trials
-
HER2 positive breast carcinoma 408 trials · 427 incl. sub-types
1 sub-type
- Triple-positive breast carcinoma 33 trials
-
Breast tumor luminal A or B 6 trials · 15 incl. sub-types
2 sub-types
- Luminal B breast carcinoma 8 trials
- Luminal A breast carcinoma 3 trials
Most studied deeper sub-types
We haven't found any trials for this condition yet. Follow it to get notified when new trials appear.